CEVR analyzes the value of strategies to improve health and health care.

About Us

News

David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow
Boston, MA – July 29, 2025 – The Center for the Evaluation of Value and Risk in Health (CEVR), part of the Institute for Clinical Research and Health ...
Read more July 29, 2025
In remembrance of John Iglehart
In remembrance of John Iglehart By Peter J. Neumann The passing of John Iglehart, the Founding Editor of Health Affairs, and a monumental figure in t...
Read more June 23, 2025
CEVR Welcomes 2025 CEA Registry Summer Fellows
CEVR Welcomes 2025 CEA Registry Summer Fellows CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship program,...
Read more June 16, 2025
View All News Items

Events

CEVR Health Policy Seminar with Nathaniel Hendrix, PhD, PharmD
Learn more
2:00–3:00 on June 17, 2025
CEVR Health Policy Seminar with Noemi Kreif, PhD
Learn more
4:00–5:00 on May 6, 2025
CEVR Health Policy Seminar with Xin Hu, PhD, MSPH
Learn more
2:00–3:00 on April 22, 2025
View All Events

Recent Publications

Health Affairs
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations
View publication
August 4, 2025
Journal of Comparative Effectiveness Research
Value assessment for health services and procedures: a call to action in a new political climate
View publication
July 18, 2025
Health Affairs Scholar
What drug characteristics explain the wide range of manufacturer rebates?
View publication
July 15, 2025
Value in Health
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
View publication
July 7, 2025
Health Affairs
Drug coverage policies and clinical guidelines alignment: Most coverage decisions include additional restrictions
View publication
July 7, 2025
Frontiers in Pharmacology
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
View publication
July 2, 2025
Value in Health
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States
View publication
June 19, 2025
Value in Health
US Drug Pricing Patterns Before Loss of Exclusivity
View publication
April 8, 2025
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases